Allogeneic adipose tissue‐derived stem cells ELIXCYTE® in chronic kidney disease: A phase I study assessing safety and clinical feasibility

The purpose of this phase I clinical trial is to assess the safety and tolerability of allogeneic adipose tissue‐derived stem cells (ADSCs) among chronic kidney disease (CKD) patients. 12 eligible CKD patients with an estimated glomerular filtration rate (eGFR) of 15–44 ml/min/1.73 m2 received one d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cellular and molecular medicine 2022-05, Vol.26 (10), p.2972-2980
Hauptverfasser:	Zheng, Cai‐Mei, Chiu, I‐Jen, Chen, Yu‐Wei, Hsu, Yung‐Ho, Hung, Lie‐Yee, Wu, Mei‐Yi, Lin, Yuh‐Feng, Liao, Chia‐Te, Hung, Yi‐Pei, Tsai, Chia‐Chu, Cherng, Yih‐Giun, Wu, Mai‐Szu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adipose Tissue Adverse events allogeneic adipose tissue‐derived stem cells Body fat chronic kidney disease Clinical trials Demography Drug dosages Epidermal growth factor receptors estimated glomerular filtration rate Feasibility Studies Female Glomerular filtration rate Hematopoietic Stem Cell Transplantation Hospitals Humans Intravenous administration Kidney diseases Male Original Oxidative stress Patients Proteinuria Quarantine Renal Insufficiency, Chronic - drug therapy Safety Stem cells Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!